| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/28/2013 | EP2629787A1 Selective targeting of the cd40l/mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis |
| 08/28/2013 | EP2629786A2 Compositions for drug administration |
| 08/28/2013 | EP2629785A1 Short peptides for enhancing muscle function |
| 08/28/2013 | EP2629782A1 Use of exosomes to promote or enhance hair growth |
| 08/28/2013 | EP2550973B1 Wound spray |
| 08/28/2013 | EP2229440B1 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 08/28/2013 | CN103270156A Wdhd1 peptides and vaccines including the same |
| 08/28/2013 | CN103270045A Methods and compositions for modulating the WNT pathway |
| 08/28/2013 | CN103270022A Agonists of neurotrophin receptors and their use as medicaments |
| 08/28/2013 | CN103269709A Treatment of sanfilippo syndrome type b |
| 08/28/2013 | CN103269708A Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| 08/28/2013 | CN103269707A Skin collagen production-romoting agent |
| 08/28/2013 | CN103265636A Novel peptide with hypoglycemic effect |
| 08/28/2013 | CN103265628A Antibacterial peptide of heterometrus spinifer and application of antibacterial peptide |
| 08/28/2013 | CN103265623A Polypeptide having protection effect on cerebral ischemic injuries, and its application |
| 08/28/2013 | CN103265621A Tubulin depolymerizing agent polypeptide and application thereof |
| 08/28/2013 | CN103265619A Tumor necrosis factor-alpha polypeptide inhibitor and application thereof |
| 08/28/2013 | CN103265618A VEGFR(vascular endothelial growth factor)2 tyrosine kinase inhibitor polypeptide and application thereof |
| 08/28/2013 | CN103265615A Human hair bioactive peptide extract product, and extraction method and application thereof |
| 08/28/2013 | CN103263664A Method for preventing and treating alzheimer's disease |
| 08/28/2013 | CN103263663A Application of antiplatelet thrombolysin in preparation of medicament for treating von willebrand factor (VWF) defective thrombosis disease |
| 08/28/2013 | CN103263662A Application of antiplatelet thrombolysin in preparation of medicament for treating thrombosis disease under condition of low shear force |
| 08/28/2013 | CN103263661A Use of an Ang-(1-7) receptor agonist in acute lung injury |
| 08/28/2013 | CN103263660A Earthworm protein for reducing blood sugar and blood pressure and eliminating diabetic complications and application pf earthworm protein |
| 08/28/2013 | CN103263441A Method for industrially purifying sheep placenta polypeptides |
| 08/28/2013 | CN103263381A Fiber type controllable drug sustained release system and preparation method thereof |
| 08/28/2013 | CN103262939A Preparation method of antioxidant activity mixed peptide originated from chick embryo |
| 08/28/2013 | CN102584981B Mutant of interferon alpha and polyethylene glycol derivatives of mutant |
| 08/28/2013 | CN102558337B Interferon alpha mutant and polyethylene glycol derivative thereof |
| 08/28/2013 | CN102477073B Oligopeptide with thrombolytic activity, preparation method thereof, and application thereof |
| 08/28/2013 | CN102397535B Insulin crystal microsphere, insulin crystal microsphere suspension, and preparation method thereof |
| 08/28/2013 | CN102250914B Protein for treating ocular vascular proliferation |
| 08/28/2013 | CN102250202B 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof |
| 08/28/2013 | CN102245759B Technique for regulating regeneration of tissue or faulty or abnormal part in organ using NELL-1 |
| 08/28/2013 | CN102198265B Method for degrading streptococcus suis biofilm by applying phage lyase |
| 08/28/2013 | CN102140473B Anti-tumor nucleic acid and polypeptide and application thereof |
| 08/28/2013 | CN102089006B Compositions and methods for producing vascular occlusion using solid-phase platelet binding agent |
| 08/28/2013 | CN101970458B Novel gamma-secretase inhibitor |
| 08/28/2013 | CN101969981B Novel crustacean androgenic gland hormone |
| 08/28/2013 | CN101945665B Composition containing arazyme for the prevention and treatment of arthritis |
| 08/28/2013 | CN101906148B Survivin-derived peptides and use thereof |
| 08/28/2013 | CN101801402B Treatment and prevention of inflammatory diseases and autoimmune diseases |
| 08/28/2013 | CN101605557B Use of the endoglycosidase Endos for treating immunoglobulin g mediated diseases |
| 08/28/2013 | CN101522707B 肌肉生长抑制素拮抗剂 Myostatin antagonists |
| 08/28/2013 | CN101489575B FKBP-L and uses thereof |
| 08/28/2013 | CN101194017B Conjugate comprising P21 protein for the treatment of cancer |
| 08/28/2013 | CN101119745B Lectin compositions and methods for modulating an immune response to an antigen |
| 08/27/2013 | US8519183 Uses for amino acid anticonvulsants |
| 08/27/2013 | US8519118 RIP140 regulation of glucose transport |
| 08/27/2013 | US8519111 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use |
| 08/27/2013 | US8519109 Tumour rejection antigens |
| 08/27/2013 | US8519103 Factor VII polypeptides that are modified and uses thereof |
| 08/27/2013 | US8519101 Nucleic acid encoding a silk protein and a method of producing a silk thread using same |
| 08/27/2013 | US8519098 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 08/27/2013 | US8519095 Poly-beta-peptides from functionalized beta-lactam monomers and antibacterial compositions containing same |
| 08/27/2013 | US8518905 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment of prevention of toll-like receptor-4-associated disorders |
| 08/27/2013 | US8518903 Use of toll-like receptor-9 agonists |
| 08/27/2013 | US8518894 Human milk peptides |
| 08/27/2013 | US8518893 Medical compositions containing ghrelin |
| 08/27/2013 | US8518892 Methods to treat symptoms of pathophysiology related to body mass |
| 08/27/2013 | US8518891 Chemotherapeutic conjugates and methods of use |
| 08/27/2013 | US8518890 Luteinizing hormone-releasing hormone receptor agonist leuprorelin, or antagonist with androgen receptor agonist for prophylaxis, treatment of prostate cancer; dehydroepiandrosterone, testosterone, dihydrotestosterone; non-steroidal androgen receptor agonist; estradiol, estrone, estriol, stilbestrol |
| 08/27/2013 | US8518887 Method of treating cancer with DLL4 antagonist and chemotherapeutic agent |
| 08/27/2013 | US8518886 Cytoprotective thereapeutic agents for the prevention of reperfusion injury following ischemic stroke |
| 08/27/2013 | US8518885 Heterocyclic peptide ketoamides |
| 08/27/2013 | US8518884 Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor |
| 08/27/2013 | US8518882 Administering choline cytidine 5-pyrophosphate which raises levels of uridine or uridine phosphate; improving memory, learning, cognition, synaptic transmission, synthesis/release of neurotransmitters, and increasing brain phospholipid levels; Alzheimer's disease |
| 08/27/2013 | US8518881 Methods for inducing superovulation in ungulates |
| 08/27/2013 | US8518880 Therapeutic agent for spinal cord injuries |
| 08/27/2013 | US8518879 Skin cream |
| 08/27/2013 | US8518878 Method for treating skin aging by administration of bFGF |
| 08/27/2013 | US8518877 Method and product for treatment and/or prevention of complications of prematurity |
| 08/27/2013 | US8518876 Composition for long-acting peptide analogs |
| 08/27/2013 | US8518875 (Carboxylalkylenephenyl)phenyloxamides, method for the production thereof and use of same as a medicament |
| 08/27/2013 | US8518874 HCV inhibitors |
| 08/27/2013 | US8518872 Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-OXO-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy |
| 08/27/2013 | US8518871 Skin permeating and cell entering (SPACE) peptides and methods of use thereof |
| 08/27/2013 | US8518870 Compositions and methods for cancer treatment using targeted carbon nanotubes |
| 08/27/2013 | US8518869 Pharmaceutical combined preparation containing a therapeutic protein |
| 08/27/2013 | US8518695 Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2 |
| 08/27/2013 | US8518661 Method of selecting and separating normal cells and specific cells by using ultrasonic waves |
| 08/27/2013 | US8518655 Means for the diagnosis and therapy of CTCL |
| 08/27/2013 | US8518455 Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose |
| 08/27/2013 | US8518454 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof |
| 08/27/2013 | US8518451 Thyroid hormone analogs and methods of use |
| 08/27/2013 | US8518436 Engineered extracellular matrices |
| 08/27/2013 | US8518430 Dry mouldable drug formulation |
| 08/27/2013 | US8518426 Topical skin care formulations |
| 08/27/2013 | US8518412 Partial peptide of lacritin |
| 08/27/2013 | US8518411 Modified TGF-β superfamily protein |
| 08/27/2013 | US8518409 System for selective cell treatment using ideotypically modulated pharmacoeffectors |
| 08/27/2013 | US8518400 Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders |
| 08/27/2013 | US8518399 Methods of treating infections originating from viruses in the herpesviridae family |
| 08/27/2013 | US8518395 CCN3 peptides and analogs thereof for therapeutic use |
| 08/27/2013 | US8518389 Methods of inhibiting proliferation or immunoglobulin production of B cells using human tumor necrosis factor receptor TR-17 polypeptides |
| 08/27/2013 | US8518105 Methods and apparatuses for coating a lesion |
| 08/27/2013 | CA2558371C Methods of modulating immune responses by modulating tim-1 and tim-4 function |
| 08/27/2013 | CA2508773C Canine rankl and methods for preparing and using the same |
| 08/27/2013 | CA2506855C Mntf peptides and compositions and methods of use |
| 08/27/2013 | CA2486918C Novel chimeric cd154 |